The detailed information on the locations of genomic alterations provided by the high-resolution CGH arrays used here allowed us to more clearly delineate the distinct genetic pathways undertaken by breast tumours displaying either BRCA1 or BRCA2 abnormalities. This evidence concerns the gene BRCA2 and breast neoplasm.